BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38716353)

  • 1. miR-34b-5p suppresses the epithelial-mesenchymal transition and metastasis in endometrial cancer AN3CA cells by targeting
    Shi L; Yang D; Dong H; Zhang X; Yang C
    Int J Clin Exp Pathol; 2024; 17(4):137-150. PubMed ID: 38716353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 3. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-186-5p upregulation inhibits proliferation, metastasis and epithelial-to-mesenchymal transition of colorectal cancer cell by targeting ZEB1.
    Li J; Xia L; Zhou Z; Zuo Z; Xu C; Song H; Cai J
    Arch Biochem Biophys; 2018 Feb; 640():53-60. PubMed ID: 29325758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-873-5p inhibits cell migration, invasion and epithelial-mesenchymal transition in colorectal cancer via targeting ZEB1.
    Li G; Xu Y; Wang S; Yan W; Zhao Q; Guo J
    Pathol Res Pract; 2019 Jan; 215(1):34-39. PubMed ID: 30455125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA UCA1 sponges miR-204-5p to promote migration, invasion and epithelial-mesenchymal transition of glioma cells via upregulation of ZEB1.
    Liang C; Yang Y; Guan J; Lv T; Qu S; Fu Q; Zhao H
    Pathol Res Pract; 2018 Sep; 214(9):1474-1481. PubMed ID: 30107990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
    Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
    Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
    [No Abstract]   [Full Text] [Related]  

  • 8. circPLOD2 knockdown suppresses endometriosis progression via the miR-216a-5p/ZEB1 axis.
    Lai G; Bu D; Chen M; Liu H; Dong L
    Reprod Biol; 2023 Jun; 23(2):100758. PubMed ID: 37023661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-525-5p Repressed Metastasis and Anoikis Resistance in Cervical Cancer via Blocking UBE2C/ZEB1/2 Signal Axis.
    Chen M; Liu LX
    Dig Dis Sci; 2020 Aug; 65(8):2442-2451. PubMed ID: 31679088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-186 regulates epithelial-mesenchymal transformation to promote nasopharyngeal carcinoma metastasis by targeting ZEB1.
    Tang L; Xiang Y; Zhou J; Li T; Jia T; Du G
    Braz J Otorhinolaryngol; 2024; 90(1):101358. PubMed ID: 37989078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circZFPM2 promotes epithelial-mesenchymal transition in endometriosis by regulating miR-205-5p/ZEB1 signalling pathway.
    Wang D; Cui L; Yang Q; Wang J
    Cell Signal; 2021 Nov; 87():110145. PubMed ID: 34517087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy.
    Meng Q; Zhai X; Yuan Y; Ji Q; Zhang P
    Braz J Med Biol Res; 2020; 53(4):e9288. PubMed ID: 32294702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-205-5p inhibits cell migration and invasion in prostatic carcinoma by targeting ZEB1.
    Li L; Li S
    Oncol Lett; 2018 Aug; 16(2):1715-1721. PubMed ID: 30008858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-199a-5p Targets ZEB1 to Inhibit the Epithelial-Mesenchymal Transition of Ovarian Ectopic Endometrial Stromal Cells Via PI3K/Akt/mTOR Signal Pathway In Vitro and In Vivo.
    Liu Y; Lu C; Fan L; Wang J; Li T; Liu Z; Sheng J; Qian R; Duan A; Lu D
    Reprod Sci; 2020 Jan; 27(1):110-118. PubMed ID: 32046378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-150-5p Alleviates Renal Tubule Epithelial Cell Fibrosis via the Inhibition of Epithelial-Mesenchymal Transition by Targeting ZEB1.
    Zhang Z; Zhang X; Gao X; Fang B; Tian S; Kang P; Zhao Y
    Int Arch Allergy Immunol; 2024 May; ():1-9. PubMed ID: 38763133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-200a-3p promotes the malignancy of endometrial carcinoma through negative regulation of epithelial-mesenchymal transition.
    Ma Y; Wang Y; Wang C; Wang Y; Hu J; Zhang Z; Dong T; Chen X
    Discov Oncol; 2024 Jun; 15(1):243. PubMed ID: 38916621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated fibroblast exosome LINC00355 promotes epithelial-mesenchymal transition and chemoresistance in colorectal cancer through the miR-34b-5p/CRKL axis.
    Hu JH; Tang HN; Wang YH
    Cancer Gene Ther; 2024 Feb; 31(2):259-272. PubMed ID: 38052858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-200a-3p regulates epithelial-mesenchymal transition and inflammation in chronic rhinosinusitis with nasal polyps by targeting ZEB1 via ERK/p38 pathway.
    Wu Y; Sun K; Tu Y; Li P; Hao D; Yu P; Chen A; Wan Y; Shi L
    Int Forum Allergy Rhinol; 2024 Jan; 14(1):41-56. PubMed ID: 37318032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.